The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Incidence and distribution of argininosuccinate synthetase deficiency in human cancers: A method for identifying cancers sensitive to arginine deprivation
Abstract
BACKGROUND: Argininosuccinate synthetase (ASS) was the first of two enzymes to convert citrulline to arginine. This pathway allowed cells to synthesize arginine from citrulline, making this amino acid nonessential for the growth of most mammalian cells. Previous studies demonstrated that several human tumor cell lines were auxotrophic for arginine due to an inability to express ASS. Selective elimination of arginine from the circulation of animals with these tumors is a potentially effective anticancer treatment. The purpose of these experiments was to determine the frequency of ASS deficiency and arginine auxotrophy in a variety of human malignant tumors. METHODS: The authors analyzed the expression of ASS by immunohistochemistry with a monoclonal antibody in a variety of human tumor biopsies. They found that the incidence of ASS deficiency varied greatly with the tumor type and tissue of origin. RESULTS: Melanoma, hepatocellular carcinoma, and prostate carcinoma were most frequently deficient in ASS. Some human cancers were almost always positive for ASS (e.g., lung and colon carcinomas). However, other human cancers, including sarcomas, invasive breast carcinoma, and renal cell carcinoma, also were sometimes ASS deficient. CONCLUSIONS: These data indicated that immunohistochemical detection of ASS may prove an effective means for determining ASS deficiency in malignant human tumors and for identifying patients most likely to respond to arginine deprivation therapy. Based on these results, human clinical trials using arginine‐degrading enzyme therapy to treat patients with advanced melanoma or hepatocellular carcinoma have been initiated. Cancer 2004;100:826–33. © 2004 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arginine: Biochemistry, Physiology, and Therapeutic Implications
Barbul, A. (1986) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607186010002227 · Cited by 530
Use of ?-asparaginase in childhood ALL
Müller, H. (1998) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(98)00015-8 · Cited by 455
Ensor, M., Holtsberg, F. W., Bomalaski, J. S., & Clark, M. A. (2002) · PubMed · Cited by 315
Self-citationScott, L., Lamb, J., Smith, S., & Wheatley, D. N. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1353 · Cited by 178
Holtsberg, F. W., Ensor, M., Steiner, M. R., Bomalaski, J. S., & Clark, M. A. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00042-1 · Cited by 155
Self-citationThe Generation of Energy by the Arginine Dihydrolase Pathway in Mycoplasma hominis 07
SCHIMKE, R. T., Berlin, C. M., Sweeney, E. W., & Carroll, W. R. (1966) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)96610-x · Cited by 149
Asselin, B. L. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4811-9_69 · Cited by 142
Gong, H., Zölzer, F., Recklinghausen, G. V., Havers, W., & Schweigerer, L. (2000) · Leukemia · doi:10.1038/sj.leu.2401763 · Cited by 138
The three asparaginases. Comparative pharmacology and optimal use in childhood leukemia.
Asselin, B. L. (1999) · PubMed · Cited by 129
In vivo anti‐tumor activity of arginine deiminase purified from Mycoplasma arginini
Takaku, H., Takase, M., Abe, S., Hayashi, H., & Miyazaki, K. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910510213 · Cited by 123
Miyazaki, K., Takaku, H., Umeda, M., Fujita, T., Huang, W. D., Kimura, T., Yamashita, J., & Horio, T. (1990) · PubMed · Cited by 115
Takaku, H., Matsumoto, M., Misawa, S., & Miyazaki, K. (1995) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1995.tb03094.x · Cited by 89
Sugimura, K., Ohno, T., Kusuyama, T., & Azuma, I. (1992) · Melanoma Research · doi:10.1097/00008390-199209000-00007 · Cited by 83
Arginine Deiminase Inhibits Cell Proliferation by Arresting Cell Cycle and Inducing Apoptosis
Gong, H., Zölzer, F., Recklinghausen, G. V., Rössler, J. K., Breit, S., Havers, W., Fotsis, T., & Schweigerer, L. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1004 · Cited by 76
Misawa, S., Aoshima, M., Takaku, H., Matsumoto, M., & Hayashi, H. (1994) · Journal of Biotechnology · doi:10.1016/0168-1656(94)90050-7 · Cited by 69
Gonzalez, G., & Byus, C. V. (1991) · PubMed · Cited by 69
Depletion of Dietary Arginine Inhibits Growth of Metastatic Tumor
Yeatman, T. J. (1991) · Archives of Surgery · doi:10.1001/archsurg.1991.01410350066010 · Cited by 67
Simberkoff, M. S., Thorbecke, G. J., & Thomas, L. (1969) · The Journal of Experimental Medicine · doi:10.1084/jem.129.6.1163 · Cited by 66
van Diggelen, O. P., Si, S., & Dm, P. (1977) · PubMed · Cited by 59
Mammalian Cell Cultures Contaminated with Pleuropneumonia-like Organisms
Kenny, G. E., & Pollock, M. E. (1963) · The Journal of Infectious Diseases · doi:10.1093/infdis/112.1.7 · Cited by 59
Dillon, B. J., Holtsberg, F. W., Ensor, M., Bomalaski, J. S., & Clark, M. A. (2002) · PubMed · Cited by 58
Self-citationKraemer, P. M. (1964) · Experimental Biology and Medicine · doi:10.3181/00379727-115-28871 · Cited by 40
THOMAS, J. B., Holtsberg, F. W., Ensor, M., Bomalaski, J. S., & Clark, M. A. (2002) · Biochemical Journal · doi:10.1042/0264-6021:3630581 · Cited by 39
Self-citationTakaku, H., Misawa, S., Hayashi, H., & Miyazaki, K. (1993) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1993.tb02821.x · Cited by 38
Growth response of stable and primary cell cultures to l-ornithine, l-citrulline, and l-arginine
TYTELL, A. A., & Neuman, R. E. (1960) · Experimental Cell Research · doi:10.1016/0014-4827(60)90225-1 · Cited by 36
The influence of arginine upon the growth rate of a transplantable tumour in the mouse
Gilroy, E. (1930) · Biochemical Journal · doi:10.1042/bj0240589 · Cited by 35
Cooney, D. A., & Rosenbluth, R. J. (1975) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60222-7 · Cited by 33
Mycoplasma (PPLO) Strains with Lytic Activity for Murine Lymphoma Cells in vitro.
Kraemer, P. M., Defend, V., Hayflick, L., & Manson, L. A. (1963) · Experimental Biology and Medicine · doi:10.3181/00379727-112-28052 · Cited by 31
Tumor growth inhibitory activity of a lymphocyte blastogenesis inhibitory factor.
Sugimura, K., Ohno, T., Fukuda, S., Wada, Y., Kimura, T., & Azuma, I. (1990) · PubMed · Cited by 26
Gill, P. G., & Pan, J. (1970) · Canadian Journal of Microbiology · doi:10.1139/m70-071 · Cited by 25
Inhibition of growth of mammalian cell cultures by extracts of arginine-utilizing mycoplasmas
Sasaki, T., Shintani, M., & Kihara, K. (1984) · In Vitro Cellular & Developmental Biology - Plant · doi:10.1007/bf02619581 · Cited by 15
Shaheen, N., Kobayashi, K., Hiroki, T., Fukushige, T., Horiuchi, M., & Saheki, T. (1994) · Enzyme and Protein · doi:10.1159/000474998 · Cited by 13
Static and dynamic aspects of amino acid pools in rat liver and Morris hepatomas 9618A and 7800.
Moyer, G. H., & Pitot, H. C. (1974) · PubMed · Cited by 13
Cited by
mTOR signalling and cellular metabolism are mutual determinants in cancer
Mossmann, D., Park, S., & Hall, M. N. (2018) · Nature reviews. Cancer · doi:10.1038/s41568-018-0074-8 · Cited by 1,088
New aspects of amino acid metabolism in cancer
Vettore, L., Westbrook, R. L., & Tennant, D. A. (2020) · British Journal of Cancer · doi:10.1038/s41416-019-0620-5 · Cited by 502
Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer
Delage, B., Fennell, D. A., Nicholson, L., McNeish, I., Lemoine, N. R., Crook, T., & Szlosarek, P. W. (2010) · International Journal of Cancer · doi:10.1002/ijc.25202 · Cited by 441
Metabolism of Amino Acids in Cancer
Wei, Z., Liu, X., Cheng, C., Yu, W., & Yi, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.603837 · Cited by 429
Dietary modifications for enhanced cancer therapy
Kanarek, N., Petrova, B., & Sabatini, D. M. (2020) · Nature · doi:10.1038/s41586-020-2124-0 · Cited by 411
Metadata
- Authors
- Dillon, B. J., Prieto, V. G., Curley, S. A., Ensor, C. M., Holtsberg, F. W., Bomalaski, J. S., & Clark, M. A.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2004-02-03
- Volume
- 100
- Issue
- 4
- Pages
- 826-833
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1588371609
- Cited by
- 314
- References
- 33
- FWCI
- 5.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.